Bray F, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
Organization, W.H. Preventing Cancer. 2020 [cited 2020 18-11-2020]; Available from: https://www.fda.gov/drugs/new-drugs-fda-cders-new-molecular-entities-and-new-therapeutic-biological-products/novel-drug-approvals-2019.
Zhou J, et al. Stem cells and cellular origins of breast cancer: updates in the rationale, controversies, and therapeutic implications. Front Oncol. 2019;9:820–820.
Article PubMed PubMed Central Google Scholar
Elbaiomy MA, et al. Clinical impact of breast cancer stem cells in metastatic breast cancer patients. J Oncol. 2020;2020:2561726.
Article CAS PubMed PubMed Central Google Scholar
Bianchini G, et al. Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease. Nat Rev Clin Oncol. 2016;13(11):674–90.
Article CAS PubMed PubMed Central Google Scholar
Greaves M, Maley CC. Clonal evolution in cancer. Nature. 2012;481(7381):306–13.
Article CAS PubMed PubMed Central Google Scholar
Tudoran OM, Balacescu O, Berindan-Neagoe I. Breast cancer stem-like cells: clinical implications and therapeutic strategies. Clujul Medical. 2016;89(2):193.
PubMed PubMed Central Google Scholar
Dragu DL, et al. Therapies targeting cancer stem cells: current trends and future challenges. World J Stem Cells. 2015;7(9):1185.
Article PubMed PubMed Central Google Scholar
Al-Hajj M, et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A. 2003;100(7):3983–8.
Article CAS PubMed PubMed Central Google Scholar
Shipitsin M, et al. Molecular definition of breast tumor heterogeneity. Cancer Cell. 2007;11(3):259–73.
Article CAS PubMed Google Scholar
Kai K, et al. Breast cancer stem cells. Breast Cancer. 2010;17(2):80–5.
Ma X, et al. Modulation of drug-resistant membrane and apoptosis proteins of breast cancer stem cells by targeting berberine liposomes. Biomaterials. 2013;34(18):4452–65.
Article CAS PubMed Google Scholar
Tam WL, et al. Protein kinase C α is a central signaling node and therapeutic target for breast cancer stem cells. Cancer Cell. 2013;24(3):347–64.
Article CAS PubMed PubMed Central Google Scholar
Singh JK, et al. Recent advances reveal IL-8 signaling as a potential key to targeting breast cancer stem cells. Breast Cancer Res. 2013;15(4):210.
Article PubMed PubMed Central Google Scholar
Gangopadhyay S, et al. Breast cancer stem cells: a novel therapeutic target. Clin Breast Cancer. 2013;13(1):7–15.
Article CAS PubMed Google Scholar
Glumac PM, LeBeau AM. The role of CD133 in cancer: a concise review. Clin Transl Med. 2018;7(1):18.
Article PubMed PubMed Central Google Scholar
Vikram R, et al. Tumorigenic and metastatic role of CD44(-/low)/CD24(-/low) cells in luminal breast cancer. Cancers. 2020;12(5):1239.
Article CAS PubMed PubMed Central Google Scholar
Chen K, Huang Y-H, Chen J-L. Understanding and targeting cancer stem cells: therapeutic implications and challenges. Acta Pharmacol Sin. 2013;34(6):732.
Article CAS PubMed PubMed Central Google Scholar
Muntimadugu E, et al. CD44 targeted chemotherapy for co-eradication of breast cancer stem cells and cancer cells using polymeric nanoparticles of salinomycin and paclitaxel. Colloids Surf B Biointerfaces. 2016;143:532–46.
Article CAS PubMed Google Scholar
Daquan Chen GW, Song W, Zhang Q. Novel CD44 receptor targeting multifunctional “nano-eggs” based on double pH-sensitive nanoparticles for co-delivery of curcumin and paclitaxel to cancer cells and cancer stem cells. J Nanopart Res. 2015;17:10.
Najjar MK, Manore SG, Regua AT, Lo HW. Antibody-drug conjugates for the treatment of HER2-positive breast cancer. Genes (Basel). 2022;13:2065.
Article CAS PubMed PubMed Central Google Scholar
Luksik AS, Yazigi E, Shah P, Jackson CM. CAR T cell therapy in glioblastoma: overcoming challenges related to antigen expression. Cancers (Basel). 2023;15:1414.
Article CAS PubMed Google Scholar
Yanze Sun XY, Wang X, et al. Bispecific antibodies in cancer therapy: Target selection and regulatory requirements. Acta Pharm Sin B. 2023;13:3583–97.
Article PubMed PubMed Central Google Scholar
Choi YH, Yu AM. ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development. Curr Pharm Des. 2014;20(5):793–807.
Article CAS PubMed PubMed Central Google Scholar
Yue-Li Sun AP, Kumar P, Chen Z-S. Role of ABC transporters in cancer chemotherapy. Chin J Cancer. 2012;31(2):51.
Article PubMed PubMed Central Google Scholar
Chuthapisith S, et al. Breast cancer chemoresistance: emerging importance of cancer stem cells. Surg Oncol. 2010;19(1):27–32.
Shivhare S, Das A. Cell density modulates chemoresistance in breast cancer cells through differential expression of ABC transporters. Mol Biol Rep. 2023;50(1):215–25.
Article CAS PubMed Google Scholar
Cui J, et al. Targeting ABCA12-controlled ceramide homeostasis inhibits breast cancer stem cell function and chemoresistance. Sci Adv. 2023;9(48):1891.
Wu CP, Ohnuma S, Ambudkar SV. Discovering natural product modulators to overcome multidrug resistance in cancer chemotherapy. Curr Pharm Biotechnol. 2011;12(4):609–20.
Article CAS PubMed PubMed Central Google Scholar
Ciocca DR, Calderwood SK. Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones. 2005;10(2):86–103.
Article CAS PubMed PubMed Central Google Scholar
Mao L. NOTCH mutations: multiple faces in human malignancies. Cancer Prev Res (Philadelphia, Pa). 2015;8:259–61.
Takebe N, Nguyen D, Yang SX. Targeting notch signaling pathway in cancer: clinical development advances and challenges. Pharmacol Ther. 2014;141(2):140–9.
Article CAS PubMed Google Scholar
Aithal MG, Rajeswari N. Role of Notch signalling pathway in cancer and its association with DNA methylation. J Genet. 2013;92(3):667–75.
Article CAS PubMed Google Scholar
Harrison H, et al. Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor. Can Res. 2010;70(2):709–18.
Hermawan A, et al. Bioinformatics and in vitro studies reveal the importance of p53, PPARG and notch signaling pathway in inhibition of breast cancer stem cells by hesperetin. Adv Pharm Bull. 2021;11(2):351.
Cejuela M, Martin-Castillo B, Menendez JA, Pernas S. Metformin and breast cancer: Where are we now? Int J Mol Sci. 2022;23(5):2705.
Article CAS PubMed PubMed Central Google Scholar
Rossini M, Martini F, Torreggiani E, Fortini F, Aquila G, Sega FV, Patergnani S, Pinton P, Maniscalco P, Cavallesco G, Rizzo P. Metformin induces apoptosis and inhibits notch1 in malignant pleural mesothelioma cells. Front Cell Dev Biol. 2021;8:534499.
Article PubMed PubMed Central Google Scholar
Chia YH, Ma CX. Hedgehog pathway inhibitors: potential applications in breast cancer. Curr Breast Cancer Rep. 2011;3:15–23.
Tsao A-N, et al. Dinaciclib inhibits the stemness of two subtypes of human breast cancer cells by targeting the FoxM1 and Hedgehog signaling pathway. Oncol Rep. 2022;47(5):1–12.
留言 (0)